An observational study in Sleep Apnea, Obstructive, sponsored by Sleep Cycle AB. Completed at 1 site in Australia. Open to participants aged 22 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-18.
Sponsored by Sleep Cycle AB · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 63 studies in Sleep Apnea, Obstructive with a site in Australia — 16 open to participants now, 19 under way, 6 of them phase 3. Sleep Apnea, Obstructive · Australia.
Among the 63 studies in Sleep Apnea, Obstructive with a site in Australia, this one is one of 10 that started in 2025, is one of 6 observational ones, and was the 63rd registered.
2,245 studies on the registry are indexed under Sleep Apnea, Obstructive; 476 are open to participants now.
Browse Sleep Apnea, Obstructive studies →16 of the 63 studies in Sleep Apnea, Obstructive with a site in Australia are open now. Recruiting first, the newest first:
Novo Nordisk A/S · Sites in Australia, United States, China and 7 more countries
Ages 18+
Novo Nordisk A/S · Sites in Australia, United States, China and 7 more countries
Ages 18+
Eli Lilly and Company · Sites in Australia, United States, Brazil and 8 more countries
Ages 18+
Restera, Inc. · Sites in Australia
Ages 18+
Flinders University · Sites in Australia
Ages 18+
A study can be open while its sites in Australia have not opened yet or have stopped. Only those recruiting at a site in Australia →
Of the 316 Sleep Apnea, Obstructive studies recruiting now, 149 (47%) set no upper age limit and 123 (39%) stop at 75 or younger; 52 take children under 18; 66 take healthy volunteers.
This study: 22 Years to 70 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
63 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 2 · Phase 2 7 · Phase 3 13 · Phase 4 1
First in 2004; this study’s year is marked. 10 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 324 is above the median of 105 across 668 observational studies indexed under Sleep Apnea, Obstructive.
Median enrollment 42 across the 57 interventional studies, 207 across the 6 observational. Of the 39 that completed or were terminated, 6 (15%) have results posted.
This tab as a report to print or save as PDF → With an account.
50 of 63 have an industry lead sponsor. The 10 most frequent:
This is the only study on the registry with Sleep Cycle AB as lead sponsor.
Sleep Cycle AB has 1 study filed under Sleep Apnea, Obstructive — fewer than ten, so there is no comparison to draw.
8 of the studies in Sleep Apnea, Obstructive with a site in Australia that are under way reach primary completion within a year, 2 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07225686Phase 3AmgenMaridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea on Positive Airway Pressure Therapy | 2027-08-20 |
| NCT07226765Phase 3AmgenMaridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea Not on Positive Airway Pressure (PAP) Therapy | 2027-08-30 |
| NCT07049744XII MedicalHypoglossal Nerve Stimulation for the Treatment of Adult Obstructive Sleep Apnea | 2026-12 |
| NCT07400861ResMedStudy of Min-Max APAP Recommender Tool | 2026-12-01 |
| NCT06930404ResMedData Collection Study to Review Novel Methods for Diagnosing Obstructive Sleep Apnea | 2026-12-30 |
Add all 8 to your calendar (.ics) → With an account.
Among the 63 studies in Sleep Apnea, Obstructive with a site in Australia, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The present study seeks to develop the software function of Sleep Cycle's app to estimate risk of obstructive sleep apnea (OSA) compared to polysomnography (PSG) in adults in an over-the-counter setting (i.e., home environment). The main questions it aims to answer are:
Researchers will compare Sleep Cycle's app to PSG (gold standard measure of diagnosing sleep apnea and measuring sleep stages) to see if Sleep Cycle's app can estimate the risk of sleep apnea.
Researchers will evaluate the sensitivity and specificity of the app to determine the research aims by comparing 2 groups: adults with an AHI \<15 and adults with an AHI of 15 or more.
Participants will:
Undertake one night of at-home PSG with 3x additional technologies: Sleep Cycle app on iPhone next to their bed + an audio recorder (both to record audio), and wear an Apple Watch to measure physiological measures (eg, heart rate).
Members of the community who have been referred to Sleep Testing Australia for a sleep study with suspected sleep apnea. These people will have been referred by their GP for an overnight PSG. They would receive this routine care whether they chose to participate in the study or not.
And adults from the community who self-identify as "good sleepers".
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Participants who are referred to Sleep Testing Australia for a sleep study as part of their routine care/as referred by their general practitioner (GP). Methods and materials will be the same as other cohort - i.e., PSG, Sleep Cycle app, audio recorder and Apple Watch
Diagnostic Test: Sleep Apnea Screening
Healthy good sleepers or those with mild sleep apnea of approximately same age/gender as the other cohort who are willing to undergo methods and materials as part of routine care of other cohort (i.e., sleep study PSG, Sleep Cycle app, audio recorder and Apple Watch).
Diagnostic Test: Sleep Apnea Screening
Sleep Cycle app with sleep apnea screening feature
AHI (Apnea-Hypopnea Index)
The AHI will be determined by the gold-standard polysomnography (PSG), and independently predicted by the Sleep Cycle app.
Time frame: During one overnight sleep study (one night)
Sleep-wake stage
The detection of wake vs 1 of 4 sleep stages (N1, N2, N3, REM sleep) will be measured by the gold-standard PSG, and independently predicted by the Sleep Cycle app.
Time frame: During one overnight sleep study (one night)
Heart Rate
Measured by ECG as part of PSG \& Apple Watch
Time frame: During one overnight sleep study (one night)
Ran from May 2025 to primary completion in Mar 2026, 9 months.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.